Nacuity Pharmaceuticals
Jami Kern is currently the Senior Vice President and Chief Clinical Officer at NACUITY PHARMACEUTICALS, INC. They also hold the title of President at Kern Consulting, Inc. Jami has a strong background in the pharmaceutical industry, with experience at Alcon Laboratories, Inc. spanning over 15 years, where they held various managerial and leadership roles in the Global Medical Affairs department. Jami holds a PhD in Biomedical Science - Molecular Biology & Biochemistry from UNT Health Science Center, an MBA from Texas Christian University, and a BA in Chemistry from Austin College.
This person is not in any teams
This person is not in any offices
Nacuity Pharmaceuticals
Nacuity Pharmaceuticals is a pharmaceutical company that aims to develop a breakthrough treatment for retinitis pigmentosa (“RP”) and potentially other ophthalmological indications.Nacuity has assembled an accomplished team and has received significant financial and technical support from the Foundation Fighting Blindness (FFB). FFB aims to driveresearch providing prevention, treatments and cures for people affected by blinding retinal diseases. FFB has invested nearly $700 million in this effort Over the last 46 years. FFB is a significant supporter of Dr. Campochiaro’s research and has committed to fund a substantial portion of Nacuity’s Phase 1 and Phase 2 trials through a milestone-based matching program grant to Nacuity in support of our NPI-001 development program.